These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Mycobacterium tuberculosis chorismate mutase: A potential target for TB. Khanapur M, Alvala M, Prabhakar M, Shiva Kumar K, Edwin RK, Sri Saranya PS, Patel RK, Bulusu G, Misra P, Pal M. Bioorg Med Chem; 2017 Mar 15; 25(6):1725-1736. PubMed ID: 28202315 [Abstract] [Full Text] [Related]
13. Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: screening of their biological activities against Ca(2+)-ATPase. Putatunda S, Chakraborty S, Ghosh S, Nandi P, Chakraborty S, Sen PC, Chakraborty A. Eur J Med Chem; 2012 Aug 15; 54():223-31. PubMed ID: 22658336 [Abstract] [Full Text] [Related]
14. 1.6 A crystal structure of the secreted chorismate mutase from Mycobacterium tuberculosis: novel fold topology revealed. Okvist M, Dey R, Sasso S, Grahn E, Kast P, Krengel U. J Mol Biol; 2006 Apr 14; 357(5):1483-99. PubMed ID: 16499927 [Abstract] [Full Text] [Related]
15. Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC. Rose Y, Ciblat S, Reddy R, Belley AC, Dietrich E, Lehoux D, McKay GA, Poirier H, Far AR, Delorme D. Bioorg Med Chem Lett; 2006 Feb 15; 16(4):891-6. PubMed ID: 16298129 [Abstract] [Full Text] [Related]
16. Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors. Lacotte P, Buisson DA, Ambroise Y. Eur J Med Chem; 2013 Apr 15; 62():722-7. PubMed ID: 23454514 [Abstract] [Full Text] [Related]
17. Charge optimization increases the potency and selectivity of a chorismate mutase inhibitor. Mandal A, Hilvert D. J Am Chem Soc; 2003 May 14; 125(19):5598-9. PubMed ID: 12733875 [Abstract] [Full Text] [Related]